217 related articles for article (PubMed ID: 27491691)
1. Laminins and cancer stem cells: Partners in crime?
Qin Y; Rodin S; Simonson OE; Hollande F
Semin Cancer Biol; 2017 Aug; 45():3-12. PubMed ID: 27491691
[TBL] [Abstract][Full Text] [Related]
2. [Laminins in Metastatic Cancer].
Maltseva DV; Rodin SA
Mol Biol (Mosk); 2018; 52(3):411-434. PubMed ID: 29989574
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
Neelakandan K; Babu P; Nair S
Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
[TBL] [Abstract][Full Text] [Related]
5. Role of ATP-binding cassette transporters in cancer initiation and progression.
Nobili S; Lapucci A; Landini I; Coronnello M; Roviello G; Mini E
Semin Cancer Biol; 2020 Feb; 60():72-95. PubMed ID: 31412294
[TBL] [Abstract][Full Text] [Related]
6. Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells.
Morata-Tarifa C; Jiménez G; García MA; Entrena JM; Griñán-Lisón C; Aguilera M; Picon-Ruiz M; Marchal JA
Sci Rep; 2016 Jan; 6():18772. PubMed ID: 26752044
[TBL] [Abstract][Full Text] [Related]
7. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and cancer stem cells.
Shigdar S; Li Y; Bhattacharya S; O'Connor M; Pu C; Lin J; Wang T; Xiang D; Kong L; Wei MQ; Zhu Y; Zhou S; Duan W
Cancer Lett; 2014 Apr; 345(2):271-8. PubMed ID: 23941828
[TBL] [Abstract][Full Text] [Related]
9. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
10. Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma.
van der Horst G; Bos L; van der Pluijm G
Mol Cancer Res; 2012 Aug; 10(8):995-1009. PubMed ID: 22714124
[TBL] [Abstract][Full Text] [Related]
11. Cancer stemness and metastatic potential of the novel tumor cell line K3: an inner mutated cell of bone marrow-derived mesenchymal stem cells.
Qian H; Ding X; Zhang J; Mao F; Sun Z; Jia H; Yin L; Wang M; Zhang X; Zhang B; Yan Y; Zhu W; Xu W
Oncotarget; 2017 Jun; 8(24):39522-39533. PubMed ID: 28465472
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling.
Manou D; Karamanos NK; Theocharis AD
Semin Cancer Biol; 2020 May; 62():108-115. PubMed ID: 31279836
[TBL] [Abstract][Full Text] [Related]
13. Semaphorins as Regulators of Phenotypic Plasticity and Functional Reprogramming of Cancer Cells.
Gurrapu S; Tamagnone L
Trends Mol Med; 2019 Apr; 25(4):303-314. PubMed ID: 30824197
[TBL] [Abstract][Full Text] [Related]
14. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms promoting physiological cells progression into tumorigenesis.
Korbut E; Ptak-Belowska A; Brzozowski T
J Physiol Pharmacol; 2012 Dec; 63(6):565-70. PubMed ID: 23388471
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs regulate tumor cell plasticity.
Liu B; Sun L; Song E
Sci China Life Sci; 2013 Oct; 56(10):886-90. PubMed ID: 24091685
[TBL] [Abstract][Full Text] [Related]
17. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
[TBL] [Abstract][Full Text] [Related]
18. Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasis.
Romano S; Tufano M; D'Arrigo P; Vigorito V; Russo S; Romano MF
Semin Cancer Biol; 2020 Feb; 60():181-190. PubMed ID: 31422157
[TBL] [Abstract][Full Text] [Related]
19. EMT as the ultimate survival mechanism of cancer cells.
Tiwari N; Gheldof A; Tatari M; Christofori G
Semin Cancer Biol; 2012 Jun; 22(3):194-207. PubMed ID: 22406545
[TBL] [Abstract][Full Text] [Related]
20. The P2X7 Receptor in the Maintenance of Cancer Stem Cells, Chemoresistance and Metastasis.
Arnaud-Sampaio VF; Rabelo ILA; Ulrich H; Lameu C
Stem Cell Rev Rep; 2020 Apr; 16(2):288-300. PubMed ID: 31813120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
